Back to User profile » Dr Jixiang Wu
Papers published by Dr Jixiang Wu:
The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions in Gastric Cancer by Targeting the miR-302b-3p/E2F Transcription Factor 3 Axis [Retraction]
Liang C, Yue C, Liang C, Ge H, Wei Z, Li G, Wu J, Huang H, Guo J
OncoTargets and Therapy 2020, 13:2523-2524
Published Date: 26 March 2020
The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions In Gastric Cancer By Targeting The miR-302b-3p/E2F Transcription Factor 3 Axis
Liang C, Yue C, Liang C, Ge H, Wei Z, Li G, Wu J, Huang H, Guo J
OncoTargets and Therapy 2019, 12:8879-8893
Published Date: 30 October 2019
Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis
Liang C, Zhao J, Ge H, Li G, Wu J
OncoTargets and Therapy 2018, 11:3561-3571
Published Date: 19 June 2018
Role of Beclin1 expression in patients with hepatocellular carcinoma: a meta-analysis
Liang C, Li W, Ge H, Zhang KT, Li GM, Wu J
OncoTargets and Therapy 2018, 11:2387-2397
Published Date: 27 April 2018
The clinicopathological and prognostic value of HSP27 in hepatocellular carcinoma: a systematic review and meta-analysis
Liang CJ, Xu YC, Ge H, Li GM, Wu JX
OncoTargets and Therapy 2018, 11:1293-1303
Published Date: 7 March 2018
Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma
Liang CJ, Xu Y, Ge H, Li G, Wu J
OncoTargets and Therapy 2018, 11:1203-1214
Published Date: 5 March 2018
Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis
Liang CJ, Xu YC, Ge H, Li GM, Wu JX
OncoTargets and Therapy 2018, 11:47-57
Published Date: 21 December 2017
Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis
Liang CJ, Xu YC, Li GM, Zhao TJ, Xia F, Li GQ, Zhang D, Wu JX
OncoTargets and Therapy 2017, 10:417-428
Published Date: 18 January 2017